Breakthrough Research

 
Stock Quotes for Breakthrough Research top ^
  • Industry: Education & Training Services
  • Sector: Consumer Defensive
  • Stock Style: Small Growth
Sign-up for 2464 investment picks

 
News Articles for Breakthrough Research top ^
SAN DIEGO, April 10, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) , a clinical-stage biotechnology company developing novel therapies for patients with heart failure and other diseases characterized by SERCA enzyme deficiencies, today announced that its lead product candidate, MYDICAR ® , has been granted breakthrough therapy designation by the U.S. Food and Drug Administration (FDA) for reducing hospitalizations for heart failure in NYHA class III or IV chronic heart failure patients who are NAb negative.
Sign-up for Celladon Receives Breakthrough Therapy Designation From FDA for MYDICAR(R), Novel, First-in-Class Therapy in Development to Treat Heart Failure investment picks
SOUTH SAN FRANCISCO, Calif., May 12, 2014 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that enrollment has begun in a Phase 3 study to evaluate the safety and efficacy of andexanet alfa, the Company's investigational recombinant Factor Xa inhibitor reversal agent, with Bayer HealthCare and Janssen Pharmaceuticals Inc.'s Factor Xa inhibitor XARELTO ® (rivaroxaban). Portola is developing andexanet alfa, an FDA-designated breakthrough therapy, as a potential first-in-class agent to reverse the anticoagulation activity of Factor Xa inhibitor-treated patients who are experiencing a major bleeding episode or who require emergency surgery.
Sign-up for Portola Pharmaceuticals Begins Enrollment in Phase 3 Study of FDA-Designated Breakthrough Therapy Andexanet Alfa and Factor Xa Inhibitor XARELTO(R) investment picks
http://media.marketwire.com/attachments/201405/TN-249489_2129_BOTE_2014_Winner.jpg A10 Networks Wins Best of TechEd Awards for Thunder Threat Protection System (TPS) http://media.marketwire.com/attachments/201402/225348_A10_Logo_2014copy.pdf.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1116252&ProfileId=051205&sourceType=1 HOUSTON, TX --
Sign-up for A10 Networks Wins Two Best of TechEd Awards: "Breakthrough Technology" and "Attendees' Pick: Microsoft Partner" for the Thunder Threat Protection System investment picks
http://media.marketwire.com/attachments/201310/67151_SGI_Logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1110933&ProfileId=051205&sourceType=1 MILPITAS, CA --
Sign-up for SGI Enables Harvard Medical School and Massachusetts General Hospital to Improve Patient Care and Accelerate Medical Breakthroughs investment picks
HAMPSTEAD, LONDON and MENLO PARK, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Anthony Nolan, the UK blood cancer charity, and Pacific Biosciences of California, Inc., (Nasdaq:PACB) announced today that Anthony Nolan is the world's first stem cell registry to invest in an innovative new technology for advanced tissue typing.
Sign-up for Anthony Nolan Revolutionizes HLA Typing With Breakthrough DNA Sequencing Technology From Pacific Biosciences investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Breakthrough Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Brazilian Companies  |  Next: Breitburn Energy Partners